Abstract
The primary role of insulin-like growth factor binding proteins (IGFBPs) is to regulate availability of IGFs for interacting with receptors, but IGFBPs perform IGF-independent actions as well. The availability and activity of IGFBPs in the circulation is influenced primarily by their concentration and structural modifications, but possibly also by interaction with major plasma proteins such as transferrin, alpha-2-macroglobulin (α2M), and fibrinogen. Four types of circulating IGFBP complexes were examined in this study by immuno- and ligand-binding assays in adults of different age. The amounts of IGFBP-3/transferrin and IGFBP-1/fibrinogen complexes were similar in middle- and old-aged persons, whereas the amounts of IGFBP-1 (or -2)/α2M monomer complexes were lower in the old-aged group and negatively correlated with total IGFBP-1 (or -2) amounts in blood. In contrast to IGFBP-1, IGFBP-2 was present in significantly greater quantities in complexes with α2M dimer than α2M monomer in older individuals. IGFBP complexes did not bind 125I-labeled IGF-I in amounts detectable by ligand blotting. According to the results of this study, the quantities of IGFBP-1 and IGFBP-2, which interact with α2M, are age-dependent and, in the case of complexes with α2M monomer, they are negatively correlated with the total circulating levels of these two IGFBPs.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- α2M:
-
alpha-2-macroglobulin
- BMI:
-
body mass index
- DU:
-
densitometric unit
- IGF:
-
insulin-like growth factor
- IGFBP:
-
IGF-binding protein
References
Ashpole, N. M., Sanders, J. E., Hodges, E. L., Yan, H., and Sonntag, W. E. (2015) Growth hormone, insulin-like growth factor-1 and the aging brain, Exp. Gerontol., 68, 76–81.
Bartke, A., List, E. O., and Kopchick, J. J. (2016) The somatotropic axis and aging: benefits of endocrine defects, Growth Horm. IGF Res., 27, 41–45.
Sperling, M. A. (2016) Traditional and novel aspects of the metabolic actions of growth hormone, Growth Horm. IGF Res., 28, 69–75.
Juul, A. (2003) Serum levels of insulin-like growth factor I and its binding proteins in health and disease, Growth Horm. IGF Res., 13, 113–170.
Hoeflich, A., and Russo, V. C. (2015) Physiology and pathophysiology of IGFBP-1 and IGFBP-2–consensus and dissent on metabolic control and malignant potential, Best Pract. Res. Clin. Endocrinol. Metab., 29, 685–700.
Ranke, M. B. (2015) Insulin-like growth factor binding-protein-3 (IGFBP-3), Best Pract. Res. Clin. Endocrinol. Metab., 29, 701–711.
Yu, H., and Rohan, T. (2000) Role of the insulin-like growth factor family in cancer development and progression, J. Nat. Cancer Inst., 92, 1472–1489.
Baxter, R. C. (1991) Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability, Acta Paed. Scand., 372 (Suppl.), 107–114.
Collet, C., and Candy, J. (1998) How many insulin-like growth factor binding proteins? Mol. Cell. Endocrinol., 139, 1–6.
Cohen, P., Ocrant, I., Fielder, P. J., Neely, E. K., Gargosky, S. E., Deal, C. I., Ceda, G. P., Youngman, O., Pham, H., Lamson, G., et al. (1992) Insulin-like growth factors (IGFs): implications for aging, Psychoneuroendocrinology, 17, 335–342.
Miljuš, G., Petrović, M., and Nedić, O. (2012) Isolation of complexes formed between insulin-like growth factor-binding protein-3 and transferrin from human serum, J. Serb. Chem. Soc., 77, 607–617.
Weinzimer, S. A., Gibson, T. B., Collett-Solberg, P. F., Khare, A., Liu, B., and Cohen, P. (2001) Transferrin is an insulin-like growth factor-binding protein-3 binding protein, J. Clin. Endocrinol. Metab., 86, 1806–1813.
Šunderić, M., Miljuš, G., and Nedić, O. (2013) Interaction of insulin-like growth factor-binding protein 2 with α2-macroglobulin in the circulation, Protein J., 32, 138–142.
Westwood, M., Aplin, J. D., Collinge, I. A., Gill, A., White, A., and Gibson, J. M. (2001) Document α2-macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis, J. Biol. Chem., 276, 41668–41674.
Gligorijević, N., and Nedić, O. (2016) Interaction between fibrinogen and insulin-like growth factor-binding protein-1 in human plasma under physiological conditions, Biochemistry (Moscow), 81, 135–140.
Fimmel, S., Borchelt, M., Kage, A., and Kottgen, E. (1993) Trace elements and carrier proteins in the aged, Arch. Gerontol. Geriatr., 19 (Suppl. 1), 67–74.
Simmonds, M. J., Meiselman, H. J., and Baskurt, O. K. (2013) Blood rheology and aging, J. Geriatric Cardiol., 10, 291–301.
Tunstall, A., Merriman, J. M., Milne, I., and James, K. (1975) Normal and pathological serum levels of α2-macroglobulins in men and mice, J. Clin. Pathol., 28, 133–139.
Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A. G., Ahn, B. W., Shaltiel, S., and Stadtman, E. R. (1990) Determination of carbonyl content in oxidatively modified proteins, Methods Enzymol., 186, 464–478.
Hossenlopp, P., Seurin, D., Segovia-Quinson, B., and Binoux, M. (1986) Identification of an insulin-like growth factor-binding protein in human cerebrospinal fluid with a selective affinity for IGF-II, FEBS Lett., 208, 439–444.
Feelders, R. A., Kuiper-Kramer, E. P. A., and Van Eijk, H. G. (1999) Structure, function and clinical significance of transferrin receptors, Clin. Chem. Lab. Med., 37, 1–10.
Rehman, A. A., Ahsan, H., and Khan, F. H. (2013) Alpha-2-macroglobulin: a physiological guardian, J. Cell. Physiol., 228, 1665–1675.
Chapin, J. C., and Hajjar, K. A. (2015) Fibrinolysis and the control of blood coagulation, Blood Rev., 29, 17–24.
Kovacs, D. M. (2000) α2-Macroglobulin in late-onset Alzheimer’s disease, Exp. Gerontol., 35, 473–479.
Mettenburg, J. M., Webb, D. J., and Gonias, S. L. (2002) Distinct binding sites in the structure of α2-macroglobulin mediate the interaction with β-amyloid peptide and growth factors, J. Biol. Chem., 277, 13338–13345.
Bhattacharjee, G., Asplin, I. R., Wu, S. M., Gawdi, G., and Pizzo, S. V. (2000) The conformation-dependent interaction of α2-macroglobulin with vascular endothelial growth factor: a novel mechanism of α2-macroglobulin/growth factor binding, J. Biol. Chem., 275, 26806–26811.
Lin, L., and Hu, K. (2014) LRP-1: functions, signaling and implications in kidney and other diseases, Int. J. Mol. Sci., 15, 22887–22901.
Ata, R., and Antonescu, C. N. (2017) Integrins and cell metabolism: an intimate relationship impacting cancer, Int. J. Mol. Sci., 18, 189.
Fougere, B., Boulanger, E., Nourhashemi, F., Guyonnet, S., and Cesari, M. (2017) Chronic inflammation: accelerator of biological aging, J. Gerontol. A Biol. Sci. Med. Sci., 72, 1218–1225.
Thieme, R., Kurz, S., Kolb, M., Debebe, T., Holtze, S., Morhart, M., Huse, K., Szafranski, K., Platzer, M., Hildebrandt, T. B., and Birkenmeier, G. (2015) Analysis of alpha-2 macroglobulin from the long-lived and cancer-resistant naked mole rat and human plasma, PLoS One, 10.
Gianuzzi, X., Palma-Ardiles, G., Hernandez-Fernandez, W., Pasupuleti, V., Hernandez, A. V., and Perez-Lopez, F. R. (2016) Insulin growth factor (IGF) 1, IGF-binding proteins and ovarian cancer risk: a systematic review and meta-analysis, Maturitas, 94, 22–29.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nedić, O., Šunderić, M., Gligorijević, N. et al. Analysis of four circulating complexes of insulin-like growth factor binding proteins in human blood during aging. Biochemistry Moscow 82, 1200–1206 (2017). https://doi.org/10.1134/S0006297917100133
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297917100133